Market closed
FibroGen/$FGEN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About FibroGen
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
Ticker
$FGEN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
225
Website
FibroGen Metrics
BasicAdvanced
$34M
-
-$0.48
0.83
-
Price and volume
Market cap
$34M
Beta
0.83
52-week high
$2.80
52-week low
$0.18
Average daily volume
5.8M
Financial strength
Current ratio
1.474
Quick ratio
0.596
Long term debt to equity
-49.105
Total debt to equity
-49.105
Interest coverage (TTM)
-15.88%
Management effectiveness
Return on assets (TTM)
-25.66%
Return on equity (TTM)
88.54%
Valuation
Price to revenue (TTM)
1.137
Price to book
-0.15
Price to tangible book (TTM)
-0.15
Price to free cash flow (TTM)
-0.243
Growth
Revenue change (TTM)
-36.71%
Earnings per share change (TTM)
-83.72%
3-year revenue growth (CAGR)
-49.88%
3-year earnings per share growth (CAGR)
-46.70%
What the Analysts think about FibroGen
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for FibroGen stock.
FibroGen Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
FibroGen Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
FibroGen News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for FibroGen stock?
FibroGen (FGEN) has a market cap of $34M as of March 22, 2025.
What is the P/E ratio for FibroGen stock?
The price to earnings (P/E) ratio for FibroGen (FGEN) stock is 0 as of March 22, 2025.
Does FibroGen stock pay dividends?
No, FibroGen (FGEN) stock does not pay dividends to its shareholders as of March 22, 2025.
When is the next FibroGen dividend payment date?
FibroGen (FGEN) stock does not pay dividends to its shareholders.
What is the beta indicator for FibroGen?
FibroGen (FGEN) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.